Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 22Recruiting 10Terminated 8Withdrawn 2Unknown 2Not yet recruiting 2Active not recruiting 2Available 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 157Gastrointestinal 67Thoracic 56Lymphoid 45Breast 44Genitourinary 42Other hematologic neoplasm 31Dermatologic 30Gynecologic 28Head & Neck 27CNS 24Sarcoma 15Plasma cell 13Myeloid 10Other 7Endocrine 6Other solid neoplasm 3Other neoplasm 3Classical hematology 3NET 2

Conditions

Neuroendocrine Tumors 51Gastro-enteropancreatic neuroendocrine tumor 10Carcinoma, Neuroendocrine 8Small Cell Lung Carcinoma 6Adenoma, Islet Cell 6Colorectal Neoplasms 4Cholangiocarcinoma 3Carcinoma, Merkel Cell 3Carcinoma, Hepatocellular 3Carcinoid Tumor 3Uterine Cervical Neoplasms 2Thyroid Neoplasms 2Salivary Gland Neoplasms 2Pheochromocytoma 2Paraganglioma 2Pancreatic Neoplasms 2Neoplasms, Unknown Primary 2Neoplasms 2Lung Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Medullary 2Brain Neoplasms 2Biliary Tract Neoplasms 2Vulvar Neoplasms 1Vipoma 1Urinary Bladder Neoplasms 1Thyroid cancer, medullary 1Thyroid Cancer, Papillary 1Thymus Neoplasms 1Testicular Neoplasms 1

Interventions

AMG 757 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Neoplasms × NET × Clear all
NCT06502977 2026-04-15

DeLLphi-307

Amgen

Phase 2 Active not recruiting
32 enrolled 9 charts
EndocrineNET

Neoplasms, Neuroendocrine Tumors

NCT03600233 2025-12-23

Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors

TaiRx, Inc.

Phase 2 Active not recruiting
34 enrolled
EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Adenoma, Islet Cell, Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡